MESM after medication: compare obstructive HCM options

Medication failure starts an options decision, not a clinic search.

Do not choose a clinic because it offers MESM. First ask a specialist to compare five paths: full sternotomy myectomy, MESM, alcohol septal ablation, continued or adjusted medical therapy, and postponement or no intervention.

Use one specialist-ready clinical packet to test which option deserves further evaluation for your anatomy, symptoms, prior medication, evidence limits, risks, and priorities.

Move to access and travel only after the evidence, candidacy assessment, accountable team, written access pathway, cost estimate, and follow-up arrangements are clear enough to judge.

This opening is decision framing only; it does not determine your treatment choice or eligibility.

Compare the five reasonable paths before choosing a clinic

Use this table to decide which options deserve specialist evaluation, not to rank them.

Reasonable options to discuss with an HCM specialist
Option	When it may be considered	How it is delivered	Evidence boundary	Material harm to clarify	What changes the choice
Classical septal myectomy	Ask whether your symptoms, obstruction, anatomy, and current medicines make an operation part of the discussion.	Classical septal myectomy removes thickened septal muscle during open-heart surgery to relieve obstruction. Septal Myectomy, Overview	Use this as a surgical reference point, then ask how the team applies it to your own imaging and goals.	Ask the surgical team to name the serious harms, likelihood, rescue plan, and follow-up burden in writing.	The guideline recommends surgical myectomy when associated cardiac disease also requires surgery and allows alcohol septal ablation when surgery is contraindicated. HCM Guideline Key Points, Key point 12
MESM	The 100-patient MESM cohort enrolled people with symptomatic hypertrophic obstructive cardiomyopathy that remained refractory to medical therapy. Minimally Invasive Electro Septal Myectomy for HOCM, Methods The number tells you this evidence came from a defined cohort; it does not by itself decide whether your anatomy, symptoms, travel plan, or risk tolerance make MESM the right option.	In the MESM literature, minimally invasive septal myectomy uses sternum-sparing right infra-axillary access rather than a catheter-only route. An innovative minimally invasive approach for HOCM, Operative Technique	Treat the published cohort as a boundary for questions, not as a clinic-selection shortcut.	Ask the MESM team to separate access-route issues from procedure-related harms and from travel-related aftercare needs.	Request a written candidacy decision that compares MESM with the other options in this table.
Alcohol septal ablation	Ask whether your team is considering this because surgery is not suitable for you or because another factor changes the balance.	Alcohol septal ablation is a catheter-based septal-reduction procedure rather than MESM. Hypertrophic Cardiomyopathy, Procedures section Alcohol septal ablation uses ethanol to make the targeted septal cells die and the thickened tissue shrink. Hypertrophic Cardiomyopathy, Procedures section	Do not compare this option with MESM as if the route, mechanism, and candidate group were the same.	Ask the interventional team to explain the main harms, monitoring plan, and what would happen if the result is incomplete.	Ask how surgical contraindications, other heart conditions, anatomy, and local expertise affect this option.
Medical therapy, including myosin inhibitors	The guideline places beta-blockers first and lists myosin inhibitors, disopyramide, or septal-reduction therapy when symptoms persist after medication trials. HCM Guideline Key Points, Key point 11	Ask for a medication plan that states the goal, monitoring schedule, stopping rules, and when the team would revisit procedures.	This row helps frame medication as an active management path, not merely a delay before an intervention.	Ask the prescribing team to document side effects to watch for, interactions to avoid, and when to seek urgent help.	Symptoms after medication trials, personal priorities, monitoring feasibility, and specialist advice can change the next step.
Postponement, monitoring, or no intervention now	The guideline says septal-reduction therapy should not be performed in asymptomatic patients with normal exercise capacity. AHA/ACC HCM Guideline Slide Deck, Slide 22, lines 697–699	Ask for a monitoring plan with review dates, warning signs, and the trigger for reopening the procedure discussion.	Hypertrophic cardiomyopathy can worsen over time and may lead to atrial fibrillation, stroke, heart failure, or sudden cardiac arrest. Hypertrophic Cardiomyopathy, Signs, symptoms and risks	Ask what harm could come from waiting, what harm could come from acting now, and how uncertainty will be reviewed.	A documented change in symptoms, test results, personal goals, or specialist assessment can change this choice.

Where the cited sources do not provide comparable numbers across all five options, the safer next step is a written specialist comparison using your own records.

Which harms and evidence limits could change the MESM decision?

Observed cohort harms

Study cohort	Reported harms	How to use the number
148-patient MESM cohort	In the 148-patient cohort, eight patients received permanent pacemakers and one patient died in hospital after an intraoperative subarachnoid haemorrhage. An innovative minimally invasive approach for HOCM, Clinical Outcomes and Table 2	This count helps you ask whether the team has a clear pacemaker and in-hospital complication plan; it does not predict your own personal chance of the same events.
100-patient MESM cohort	In the 100-patient cohort, four patients received permanent pacemakers, while no in-hospital death or iatrogenic ventricular-septal defect was reported. Minimally Invasive Electro Septal Myectomy for HOCM, Abstract Results	This count gives another cohort-bound harm observation to compare with your written clinical packet; it does not prove that the same result will apply to you.

Comparison limit

Randomised comparisons of MESM against sternotomy myectomy have not been performed. Minimally Invasive Septal Myectomy for HOCM, Operative rationale

Use these observations as decision material, not as a ranking of MESM against sternotomy myectomy, alcohol septal ablation, adjusted medication, postponement, or no intervention.

Before choosing a clinic or travel plan, ask for a written explanation of candidacy, the accountable team, access pathway, cost estimate, and follow-up arrangements.

Candidacy and workup

Treat this as a specialist-review preparation step, not as proof that MESM fits you.

The AHA and ACC guideline says septal-reduction therapy must be performed at experienced hypertrophic-cardiomyopathy centres. HCM Guideline Key Points, Key point 12

Your review packet

Bring one packet that lets each team compare the same case rather than reacting to a programme description.

The MESM programme asks for transthoracic echocardiography with gradients and systolic-anterior-motion assessment, cardiac CT or MRI when available, and a clinical summary with current medication. Minimally Invasive Septal Myectomy for HOCM, Referral lines 300–309

The guideline recommends coronary angiography before septal-reduction therapy. HCM Guideline Key Points, Key point 7

What each record changes

Use the clinical summary and medication list to frame the symptom-and-treatment question already raised in the comparison.
Use echocardiography to make the obstruction-and-valve-motion question explicit for review.
Use available CT or MRI to support an anatomy-dependent discussion rather than a programme-first choice.
Use coronary assessment as a pre-treatment planning checkpoint before a septal-reduction decision.

The sources here support review requirements and referral records; they do not establish personal eligibility or a complete MESM-specific contraindication list.

What MESM means

Use this block as a naming guide before you read the operative sequence or contact a programme.

The core name

MESM expands to minimally invasive electro septal myectomy. Minimally Invasive Septal Myectomy for HOCM, Homepage lines 4–7

In patient language, treat MESM as a named septal-myectomy route, not as proof that this route fits your case.

The MESM programme describes the operation as a modified transaortic Morrow procedure. Minimally Invasive Septal Myectomy for HOCM, Operative essentials

That wording is useful for asking whether the team means this named programme or a different septal procedure.

Names you may encounter

Chinese professional reporting pairs 微创室间隔电切术 with MESM. AATS中国之声｜微创室间隔电切术, Title and opening paragraphs
Transaortic septal myectomy via right infra-axillary incision is the title terminology of the 148-patient cohort. An innovative minimally invasive approach for HOCM, Title and Methods
Here, 148 helps you identify the cohort being discussed; it does not decide whether MESM, another operation, ablation, medication, or waiting is the right path for you.
微创Morrow术 appears as Chinese shorthand on a public physician profile. 崔勇医生介绍, Profile introduction

When a clinic, article, or profile uses a nearby name, ask them to map it back to the exact procedure they are offering in writing.

Broad wording such as minimally invasive septal myectomy should be treated as a category clue, not as a guaranteed synonym for MESM.

Keep the classical operation and alcohol-ablation distinction in the comparison section, where those options can be weighed side by side instead of folded into one name.

What the documented MESM operation physically involves

Read this as a source-bounded procedure map, not as a personal treatment recommendation.

MESM is described as a modified Morrow procedure performed through a five-centimetre right infra-axillary incision in the third intercostal space with electrocautery. Minimally Invasive Septal Myectomy for HOCM (FAQ and operative essentials)

The five-centimetre figure gives a stated incision length in the programme description; it does not tell you whether that access is appropriate, safer, or complete for your own case.

First, access-route wording: right infra-axillary.
Second, incision-size wording: five-centimetre.
Third, anatomical-location wording: third intercostal space.
Fourth, surgical-lineage wording: modified Morrow procedure.
Fifth, tissue-action wording: electrocautery.

For preparation, carry forward the specialist-ready packet from the workup section instead of rebuilding it here.

After this, use the evidence and outcomes section to judge what this description can and cannot support.

Outcomes and certainty

Use this block to separate what the cohorts reported from what they cannot decide for an individual patient.

Two cohort windows

The 148-patient series enrolled consecutive patients treated from September 2021 through July 2023 at one centre. Source: An innovative minimally invasive approach for HOCM; locator: Patient Selection

This size and date window helps you keep the cohort separate, but it does not let you infer your own outcome or compare this programme with another provider.
The 100-patient series enrolled consecutive patients treated from November 2023 through May 2024 at one centre. Source: Minimally Invasive Electro Septal Myectomy for HOCM; locator: Abstract Methods

This size and date window helps you keep the cohort separate, but it does not show whether a patient with your anatomy and risk profile would be offered MESM.

The reported enrolment windows do not overlap, so the two cohorts are independent by patient dates but not independent external confirmation. Source: Publisher cohort page; locator: Methods and cited later cohort

The count of two cohorts can support a source-scope question, not a conclusion that the finding has been independently reproduced elsewhere.

PubMed lists Zhejiang provincial research support for the 100-patient paper and reports that its authors disclosed no conflicts of interest. Source: Minimally Invasive Electro Septal Myectomy for HOCM; locator: Conflict statement and Grants and funding

The 100-patient label ties this disclosure to that paper only; it does not rate the treatment, the provider, or the strength of the result.

Reported gradient change

The 100-patient cohort reported a mean left-ventricular-outflow-tract gradient change from 85.8 to 8.4 millimetres of mercury after surgery. Source: Minimally Invasive Electro Septal Myectomy for HOCM; locator: Abstract Results

Read the before-and-after numbers as a cohort average in the reported group, not as a forecast for one patient.

The numbers tell you the reported direction and size of the measured change in that cohort; they do not tell you symptom change, durability, risk, or whether MESM is preferable to another option for you.

Limits of certainty

The 148-patient report described only early results and called for continued long-term follow-up. Source: Publisher cohort page; locator: Limitations paragraph

The 148-patient label helps you locate the early-results paper, but it does not remove the need to ask what longer follow-up now exists for patients like you.

A specialist-ready discussion should ask whether the same evidence packet, candidacy assessment, accountable team, written access pathway, cost estimate, and follow-up arrangements make further MESM evaluation reasonable.

What the named MESM team evidence does and does not establish

Use this section after MESM is already worth specialist evaluation; it is a team-evidence check, not a treatment recommendation.

Documented surgical role

Identification portrait attributed to cardiac surgeon Yong Cui — Identification only; this portrait is not outcome evidence and does not confirm operator assignment for an individual patient.

PubMed affiliates Yong Cui with the Heart Center and Department of Cardiovascular Surgery at Zhejiang Provincial People’s Hospital in Hangzhou. Minimally Invasive Electro Septal Myectomy for HOCM, Affiliation 4

This supports institutional affiliation only; ask separately whether that affiliation matches the team proposed for your own care.

A professional training report states that Yong Cui demonstrated MESM during live surgical teaching. 微创心脏大血管手术围术期管理高级研修班, Live-operation paragraph

This supports a reported teaching demonstration, not a promise that the same person will operate on a future patient.

The MESM programme names Yong Cui as its cardiac surgeon and technique creator. Minimally Invasive Septal Myectomy for HOCM, Team section

This is the strongest named surgical-role evidence in this block; still request written confirmation of the treating decision-maker, operator, and supervising team.

Diagnostic and perioperative roles

The MESM programme names Wang Zhenzhen in echocardiography and diagnosis. Minimally Invasive Septal Myectomy for HOCM, Team section
Treat this as a programme-defined diagnostic role, not surgical-operator evidence.
The MESM programme names Yan Meijuan in anaesthesia and ultra-fast-track care. Minimally Invasive Septal Myectomy for HOCM, Team section
Treat this as a programme-defined anaesthesia and perioperative-care role, not surgical-operator evidence.

What to ask before relying on the team page

Ask in writing: who makes the final treatment decision, who would personally perform the procedure if MESM is chosen, who oversees anaesthesia and perioperative care, and who is accountable for follow-up.

Do not use this evidence to infer current intake, price, travel timing, personal assignment, or individual case volume.

Access and travel

Do not choose a clinic because it offers MESM.

Ask an HCM specialist to compare MESM with the other choices in your clinical packet before you treat programme access as a travel reason.

What is documented

The MESM programme page names Zhejiang Provincial People’s Hospital in Hangzhou, China. Minimally Invasive Septal Myectomy for HOCM, Homepage lines 10–12

This review documents one MESM centre worldwide, which is a documented-centre count rather than a market total. Minimally Invasive Septal Myectomy for HOCM, Homepage lines 10–12

The word ‘one’ tells you how narrow this documented evidence set is; it does not prove that no other centre exists or that this centre is right for you.

Use the cited programme page only for the named place and evidence scope; use direct written enquiry for operational access questions.

Answers needed before travel

Do not book travel until the programme has answered the access and aftercare questions in writing.

Ask whether international patients can be evaluated for MESM, what records must be sent, and who is accountable for the written answer.
Ask whether remote review is possible before travel, who performs it, and whether the reply is a preliminary screen or a treatment recommendation.
Ask which languages are available for medical discussion, consent, discharge instructions, and urgent questions.
Ask what local stay is expected from arrival through clearance to travel home.
Use the city named in the programme evidence in every enquiry and travel note; do not substitute another city when arranging records review or itinerary planning.
Ask for a written estimate process before committing to flights or accommodation.
Ask for a written responsibility plan naming contacts for routine follow-up, urgent complications, record transfer, and care after you return home.

Address the enquiry to the programme and require the reply to name the person or office accountable for intake.

Treat public-facing contact points as the start of enquiry, not as proof that MESM-specific intake, language support, remote review, or follow-up are available to you.

Get A Written Estimate Before Comparing Costs

No patient-facing MESM price should be inferred here; treat cost as a written-enquiry item.

Ask for a dated written estimate in a stated currency.
Ask whether the estimate is preliminary or final.
Ask the provider to itemise professional fees, hospital care, tests and imaging, medicines, travel-support services, and follow-up services as included, excluded, or undecided.
Ask which findings in your records could change the estimate.
Ask which services would need separate payment or separate approval.
Do not use model estimates, unrelated market ranges, fixed exchange rates, starting prices, or assumed packages as substitutes for a written estimate.
Use only the supplied MESM programme route for this enquiry: MESM Surgery.

Recovery evidence and aftercare questions

What the cohort reported

The 148-patient study reported a mean hospital stay of 9.7 days with a standard deviation of 4.9 days. An innovative minimally invasive approach for HOCM, Clinical Outcomes

Read that number as study-level recovery evidence, not as a promised personal hospital stay or a local travel-duration estimate.

Your written aftercare plan

Before choosing a clinic or travelling, ask for a written aftercare plan that answers these questions.

Who is the named routine follow-up contact?
Who receives complication questions, and through which contact route?
How will records be transferred to the clinician continuing care after travel?
What is the post-travel rescue route if the plan stops fitting the patient’s condition?
Where is the separate longer-term HCM surveillance plan documented?

Because this block has no supported urgent-warning-sign list, treat warning signs as a written-plan item rather than an inferred checklist.

Long-term monitoring after the treatment decision

Use long-term follow-up planning to separate general HCM surveillance from the treating programme’s own aftercare responsibilities.

The guideline recommends repeating transthoracic echocardiography every one to two years or sooner when clinical status changes. HCM Guideline Key Points, Key point 3
This interval helps you plan ongoing surveillance; it does not decide whether MESM, sternotomy myectomy, alcohol septal ablation, medication adjustment, or postponement is right for you.
The guideline includes a twelve-lead electrocardiogram in initial and annual follow-up and recommends twenty-four to forty-eight hours of ambulatory monitoring. HCM Guideline Key Points, Key point 6
These timeframes identify rhythm monitoring to keep in the follow-up plan; they do not assign responsibility for testing, travel backup, or emergency escalation.

Before choosing a clinic or travelling, ask who owns routine monitoring, who receives results, and who responds if symptoms or test findings change after you return home.

This block uses only the assigned guideline monitoring claims and does not add lifestyle, work, caregiving, relationship, genetic, or family-screening advice.

Questions and name checks before choosing a route

Ask every programme the same questions, then compare the written answers with the specialist’s option assessment.

Questions for the specialist

Which five paths were considered for me: full sternotomy myectomy, MESM, alcohol septal ablation, continued or adjusted medical therapy, and postponement or no intervention?
Why does the proposal fit my anatomy, symptoms, medication history, and priorities?
Who makes the final recommendation, and how is disagreement handled before I commit?
Who would operate or perform the intervention, and what role would each named clinician have?
Which centre-specific outcome information applies to patients like me, and which parts should not be carried over to my situation?

Questions for the programme

What written access pathway confirms assessment, acceptance, scheduling, and treatment steps?
What local-stay assumptions should I plan around, and what could change them?
What itemised price estimate can I review before travel, and which items remain outside it?
Who owns routine follow-up after I return home?
Who answers an urgent complication concern during travel and after return?
How will records, images, operative notes, and discharge documents be transferred to my local clinician?
What written rescue pathway applies if symptoms, wound concerns, or test results need review after travel?

If an answer is missing or only verbal, keep that comparison item unresolved.

Procedure-name questions

Use these entries only to resolve names and adjacent procedure labels; they do not answer personal eligibility, access, price, operator assignment, or aftercare ownership.

What does MESM stand for?: MESM means minimally invasive electro septal myectomy. Minimally Invasive Septal Myectomy for HOCM, Homepage wordmark
What procedure does Minimally Invasive Electro-Septal Myectomy name?: Minimally Invasive Electro-Septal Myectomy is a transaortic surgical myectomy using right infra-axillary access and electrocautery-assisted resection. Minimally Invasive Electro Septal Myectomy for HOCM, Abstract and Methods
What does minimally invasive septal myectomy mean in this source set?: Here, minimally invasive septal myectomy means sternum-sparing access through the right infra-axillary chest wall. An innovative minimally invasive approach for HOCM, Operative Technique
How should transaortic septal myectomy be read in the predecessor cohort?: It is the predecessor cohort’s title term for the same access route later labelled MESM. An innovative minimally invasive approach for HOCM, Title and programme evidence list
How does the programme describe its relationship to Morrow terminology?: The programme describes MESM as a modified transaortic Morrow procedure. Minimally Invasive Septal Myectomy for HOCM, FAQ
Which Chinese term is paired with MESM?: 微创室间隔电切术 is the documented Chinese name paired with MESM. AATS中国之声｜微创室间隔电切术, Title
What Chinese shorthand appears for minimally invasive Morrow surgery?: 微创Morrow术 is Chinese shorthand used for minimally invasive Morrow surgery. 崔勇医生介绍, Profile introduction
How is classical surgical septal myectomy distinct as a procedure label?: Classical surgical septal myectomy removes obstructing septal muscle during open-heart surgery. Septal Myectomy, Overview
How is alcohol septal ablation kept separate as a procedure label?: Alcohol septal ablation is a distinct catheter-based procedure. Hypertrophic Cardiomyopathy, Procedures section

Sources and accountability

Use this page only when each decision-relevant sentence keeps its source beside the sentence, not only in a final list.

How claims are sourced

Read each nearby citation as a scope check: guideline recommendation, cohort observation, programme description, professional reporting, physician-profile terminology, or portrait identification.

Guideline sources: ACC HCM guideline key points; AHA/ACC guideline slide deck; American Heart Association HCM overview.
Cohort sources: 148-patient cohort; 100-patient PubMed record; publisher cohort page.
Programme and terminology sources: MESM programme; Chinese MESM terminology report; professional teaching report.
Identity source: Yong Cui physician profile.
Portrait source: Sohu portrait source, for identification context only if a portrait is shown.

A source index can help you find documents, but it does not replace checking the citation beside the claim that affects your choice.

When a sentence depends on a cohort, keep the cohort boundary attached to it; when it depends on a programme page or professional report, keep that source type visible.

Review and role status

No clinical reviewer is assigned in the supplied accountability record.

Use that absence as a caution: do not treat this page as a substitute for an individual specialist assessment.

Bookimed role limits should be read as editorial and access-context limits, not as proof that a procedure, clinic, travel plan, or price is right for you.

Before acting, ask the treating team to confirm the source-backed details that matter to your own case in writing.

MESM after medication no longer controls obstructive HCM